No Data
Express News | Pulike Biological Engineering,Inc.: "Minitan Soft Ointment" obtained a new veterinary drug registration certificate.
Pulike biological engineering,inc. (603566.SH): Actively promoting the layout of companion animal-related products.
Gelonghui November 26th | Pulike Biological Engineering,Inc. (603566.SH) stated on the investor interaction platform that the company's main business products already cover the prevention and treatment of animal diseases such as livestock, poultry, and pets; the company has long adhered to a "full category" global strategy, fully utilizing independent research and development and technical cooperation to improve the layout of pig and poultry products, and actively promote the layout of companion animal-related products.
Pulike Biological Engineering,Inc.(603566.SH): There is currently no plan to acquire One Health.
Gelonghui November 26 | Pulike Biological Engineering,Inc. (603566.SH) stated on the investor interaction platform that Yichong Health and Pulike Biological Engineering,Inc. are controlled by the same controlling shareholder, affiliated companies of the company, but the company does not hold shares of Yichong Health. Yichong Health is committed to building a first-class chain of pet hospitals, improving the standardization level and service quality of the pet diagnosis and treatment industry. The company currently has no plans to acquire Yichong Health.
pulike biological engineering,inc. (603566): The high expense ratio puts short-term performance under pressure, waiting patiently for the recovery of performance in the later cycle.
High expense ratio puts short-term performance under pressure, waiting for performance recovery in the future cycle, maintaining a 'buy' rating. The company released the third quarter report of 2024, with a revenue of 0.762 billion yuan for 2024 Q1-Q3 (-17.96% year-on-year), net income attributable to shareholders.
pulike biological engineering,inc. (603566.SH): Cumulatively repurchased 1.2% of shares, company completes repurchase
Gelonghui, November 1st | Pulike Biological Engineering, Inc. (603566.SH) announced that on November 1, 2024, the company completed the repurchase, actually repurchasing 4,142,900 shares of the company's stock, accounting for 1.20% of the total share capital of the company. The highest repurchase price was 22.48 yuan/share, the lowest price was 11.66 yuan/share, and the average repurchase price was 14.56 yuan/share. The total amount paid was 60,328,181 yuan (excluding transaction costs).
Express News | Galaxy Securities: Focus on significant changes in cost margins, high-quality pig enterprises with good funding.
No Data
No Data